Identification of molecular apocrine breast tumours by microarray analysis

[1]  R. Walker,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2005 .

[2]  Ingo K Mellinghoff,et al.  HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability. , 2004, Cancer cell.

[3]  B. Dutrillaux,et al.  Characterization of a new cytogenetic subtype of ductal breast carcinomas , 2004, Oncogene.

[4]  Daniel Birnbaum,et al.  Identification and validation of an ERBB2 gene expression signature in breast cancers , 2004, Oncogene.

[5]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[6]  H. Denk,et al.  Androgen receptors frequently are expressed in breast carcinomas , 2003, Cancer.

[7]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[9]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[10]  J. Reis-Filho,et al.  Oncogenes, granules and breast cancer: what has c-myc to do with apocrine changes? , 2002, Breast.

[11]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Biaoyang Lin,et al.  The program of androgen-responsive genes in neoplastic prostate epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Dickson,et al.  Roles of androgens in the development, growth, and carcinogenesis of the mammary gland , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[15]  R. Spang,et al.  Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Joe W. Gray,et al.  Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Bélanger,et al.  Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. , 2001, Biochemistry.

[19]  C. Graham,et al.  Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. , 2000, Biochemical and biophysical research communications.

[20]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[21]  A. Selim,et al.  c‐erbB2 oncoprotein expression, gene amplification, and chromosome 17 aneusomy in apocrine adenosis of the breast , 2000, The Journal of pathology.

[22]  H. Wennbo,et al.  The role of prolactin and growth hormone in breast cancer , 2000, Oncogene.

[23]  T. Libermann,et al.  PDEF, a Novel Prostate Epithelium-specific Ets Transcription Factor, Interacts with the Androgen Receptor and Activates Prostate-specific Antigen Gene Expression* , 2000, The Journal of Biological Chemistry.

[24]  A. Selim,et al.  Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors. , 1999, Journal of clinical pathology.

[25]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Claycomb,et al.  Adrenomedullin Gene Expression Is Developmentally Regulated and Induced by Hypoxia in Rat Ventricular Cardiac Myocytes* , 1998, The Journal of Biological Chemistry.

[27]  D. Horsfall,et al.  Androgens induce divergent proliferative responses in human breast cancer cell lines , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  D. Goeddel,et al.  Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.

[29]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[30]  M. Dowsett,et al.  Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer. , 1991, British Journal of Cancer.

[31]  W. Frable,et al.  Carcinoma of the breast. Histologic and clinical features of apocrine tumors , 1968, Cancer.

[32]  E. Diamandis,et al.  Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer , 2004, Breast Cancer Research and Treatment.

[33]  W. Tilley,et al.  Role of the Androgen Receptor in Human Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.

[34]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .

[35]  C. Haagensen.  Diseases of the Breast , 1971 .